Maureen McEnroe

No open positions remaining

Finance

Consumer Services

Profile

Ms. Maureen McEnroe, CFA MBA, is an Advisor at Iguana Healthcare Management LLC.
She provides independent buy-side analysis through the firm MAC Healthcare Consulting.
For the last seven years, she has worked with a variety of hedge funds and mutual funds giving long/short trading and investment ideas in the healthcare services sector.
Prior to founding MAC Healthcare Consulting, Ms. McEnroe was the Healthcare Services Portfolio Manager at Merlin BioMed Group.
She worked at Merlin BioMed from July of 1999 through December 2002.
Before moving to the buy-side, she had almost ten years of sell-side research and banking experience at Prudential, Merrill Lynch, and HCF/Brenner Securities.
She was the Director of Healthcare Research at HCF/Brenner, and a senior biotechnology and bioinstrumentation at Merrill Lynch Capital Markets from 1990 until 1995.
Prior to that, she was a Junior Biotechnology analyst at Prudential Securities.
She also had a successful nursing career at Memorial Sloan Kettering Cancer Center.
Ms. McEnroe received an MBA from the Stern School of Business at New York University in 1989 and a Nursing degree from the Columbia University School of Nursing in 1983.
She is a Chartered Financial Analyst.

Former positions of Maureen McEnroe

Companies	Position	End
Merlin Biomed Group Hedge Funds Merlin Biomed Group Hedge Funds Investment ManagersFinance Merlin BioMed invests globally in public and private healthcare companies. The firm's hedge funds and long-term appreciation fund seek maximum capital appreciation from broad-based, global investment in small-, mid- and large-cap public and private companies in the areas of biotechnology, pharmaceuticals, medical devices, healthcare services and research products/services. This investment objective is characterized by an intensive, research-oriented, fundamental, bottom-up approach with a focus on new product innovation as a driver of sales and earnings growth. For private equity, the MerlinNexus objective is to realize long-term capital appreciation from investments in late-stage private companies, PIPEs (private investments in public entities) and select open market transactions. The fund is invested in all segments of the healthcare industry, with an emphasis on product-driven life sciences companies developing breakthrough products that meet clinical needs and can positively alter disease course and associated costs.	Portfolio Manager-Equities	30/11/2002
Merrill Lynch Capital Markets Merrill Lynch Capital Markets Investment Banks/BrokersFinance Security Brokers Dealers and Flotation Companies	Corporate Officer/Principal	31/12/1994
Brenner Securities Corp Brenner Securities Corp Investment Banks/BrokersFinance Full service securities brokerage firm	Corporate Officer/Principal	-
Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/ Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/ Investment Banks/BrokersFinance Provides brokerage services	Corporate Officer/Principal	-
Prudential Securities Prudential Securities Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	-

See the detail of Maureen McEnroe's experience

Training of Maureen McEnroe

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Maureen McEnroe's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	8
Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/ Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/ Investment Banks/BrokersFinance Provides brokerage services	Finance
Prudential Securities Prudential Securities Investment Banks/BrokersFinance Provides brokerage services	Finance
Merlin Biomed Group Hedge Funds Merlin Biomed Group Hedge Funds Investment ManagersFinance Merlin BioMed invests globally in public and private healthcare companies. The firm's hedge funds and long-term appreciation fund seek maximum capital appreciation from broad-based, global investment in small-, mid- and large-cap public and private companies in the areas of biotechnology, pharmaceuticals, medical devices, healthcare services and research products/services. This investment objective is characterized by an intensive, research-oriented, fundamental, bottom-up approach with a focus on new product innovation as a driver of sales and earnings growth. For private equity, the MerlinNexus objective is to realize long-term capital appreciation from investments in late-stage private companies, PIPEs (private investments in public entities) and select open market transactions. The fund is invested in all segments of the healthcare industry, with an emphasis on product-driven life sciences companies developing breakthrough products that meet clinical needs and can positively alter disease course and associated costs.	Finance
The Trustees of Columbia University in The City of New York The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Brenner Securities Corp Brenner Securities Corp Investment Banks/BrokersFinance Full service securities brokerage firm	Finance
New York University New York University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Merrill Lynch Capital Markets Merrill Lynch Capital Markets Investment Banks/BrokersFinance Security Brokers Dealers and Flotation Companies	Finance
Iguana Healthcare Management LLC Iguana Healthcare Management LLC Investment ManagersFinance Iguana Healthcare Management Healthcare’s investment objective is for its clients to maximum returns from investing long and short globally in public companies in the life sciences industry while actively managing both sector and global risk with an eye on capital preservation. The broad base of investment opportunities includes, but is not limited to companies focusing on biotechnology, branded pharmaceuticals, generic pharmaceutics, medical devices and medical supplies, healthcare service providers, and healthcare information technology. Iguana Healthcare clients’ portfolios are constructed using a multi-factorial approach with a focus on balancing risk and liquidity with expected returns on individual stocks and with their impact on upon overall portfolio concentration. Portfolios are constructed stock-by-stock and not sub-sector by sub-sector.	Finance